ATMRD 2025

Recognition of dementia in its earliest stages is now critical with the advent of new treatments, but diagnosis can be challenging given the variable patient presentations and numerous contributing causes (eg, Alzheimer’s, Lewy body dementia, vascular trauma, etc.). This session discusses the diagnosis and treatment of dementia, including the use of diagnostic biomarker tests and efficacy/safety of medications targeting amyloid-beta.